BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23747564)

  • 1. Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.
    Gallicchio MA; Bach LA
    Biochim Biophys Acta; 2013 Dec; 1833(12):2922-2932. PubMed ID: 23747564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma.
    Gallicchio MA; Bach LA
    Biochim Biophys Acta; 2010 Aug; 1803(8):919-30. PubMed ID: 20435073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.
    Gallicchio MA; McRobert EA; Tikoo A; Cooper ME; Bach LA
    J Am Soc Nephrol; 2006 Feb; 17(2):414-21. PubMed ID: 16371434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.
    Xiang G; Schinzel R; Simm A; Münch G; Sebekova K; Kasper M; Niwa T; Schmitz C; Heidland A
    Nephrol Dial Transplant; 2001 Aug; 16(8):1562-9. PubMed ID: 11477156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.
    Ozdemir AM; Hopfer U; Rosca MV; Fan XJ; Monnier VM; Weiss MF
    Am J Nephrol; 2008; 28(1):14-24. PubMed ID: 17890854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin.
    Xiang G; Schinzel R; Simm A; Sebekova K; Heidland A
    Kidney Int Suppl; 2001 Feb; 78():S53-7. PubMed ID: 11168983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
    Sebeková K; Schinzel R; Ling H; Simm A; Xiang G; Gekle M; Münch G; Vamvakas S; Heidland A
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
    Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
    McRobert EA; Bach LA
    Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of macropinocytosis by p21-activated kinase-1.
    Dharmawardhane S; Schürmann A; Sells MA; Chernoff J; Schmid SL; Bokoch GM
    Mol Biol Cell; 2000 Oct; 11(10):3341-52. PubMed ID: 11029040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
    Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M
    Kidney Int; 2003 Feb; 63(2):464-73. PubMed ID: 12631112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
    Oldfield MD; Bach LA; Forbes JM; Nikolic-Paterson D; McRobert A; Thallas V; Atkins RC; Osicka T; Jerums G; Cooper ME
    J Clin Invest; 2001 Dec; 108(12):1853-63. PubMed ID: 11748269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
    Ozdemir AM; Hopfer U; Erhard P; Monnier VM; Weiss MF
    Ann N Y Acad Sci; 2005 Jun; 1043():625-36. PubMed ID: 16037286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Na superset+/H superset+ exchange decreases albumin-induced NF-kappaB activation in renal proximal tubular cell lines (OK and LLC-PK1 cells).
    Drumm K; Gassner B; Silbernagl S; Gekle M
    Eur J Med Res; 2001 Oct; 6(10):422-32. PubMed ID: 11698229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.
    Delpeut S; Sisson G; Black KM; Richardson CD
    J Virol; 2017 May; 91(10):. PubMed ID: 28250131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.